Technology | PET-CT | October 05, 2016

GE Healthcare Announces FDA Clearance of Discovery MI PET/CT System

New digital PET/CT system enables clinicians to detect smaller lesions

GE Healthcare, Discovery MI PET/CT system, FDA clearance, RSNA 2016

October 5, 2016 — GE Healthcare recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery MI digital positron emission tomography (PET)/computed tomography (CT) system and shared a series of first clinical images. Built with technology allowing significantly better small lesion detectability, Discovery MI can help clinicians in their efforts to diagnose and stage disease earlier.

The first unit has been installed at the Stanford University School of Medicine, Stanford, Calif.  

Discovery MI was created to help clinicians achieve their primary goal of diagnosing and staging disease earlier and to better guide their treatment strategies. It also enables more compelling research with more novel, faster decaying tracers. A key component in delivering these desired outcomes is Discovery MI’s LightBurst Digital Detector. This detector delivers up to two times improvement in volumetric resolution, enabling small lesion detectability, and has the highest NEMA sensitivity of any time-of-flight (TOF)/PET system in the industry, according to GE.

Discovery MI may also enhance clinicians’ diagnostic service offerings in oncology and expand PET’s impact in neurology, cardiology and beyond. These expanded capabilities are enabled by the ability to increase low-yield tracer capability with protocols that reduce dose by up to 50 percent, allowing clinicians to pursue research without impacting image quality.

This system also features the latest diagnostic CT innovations helping to deliver 100 percent better spatial resolution, with no increase in image noise with ASiR-V. And with Smart Metal Artifact Reduction (MAR), Discovery MI helps virtually eliminate streaks and shadows from metal artifacts, saving valuable time previously spent correcting images, increasing the number of successful scans for patients.

For more information: www.gehealthcare.com

Related Content

GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption
News | Nuclear Imaging | September 27, 2018
Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of...
Videos | Nuclear Imaging | August 21, 2018
Rami Doukky, M.D., professor of medicine, preventive medicine and radiology, and chief of the Division of Cardiology
ASNC Announces Keynote Speakers for 2018 Annual Scientific Session
News | Nuclear Imaging | August 08, 2018
August 8, 2018 — The American Society of Nuclear Cardiology’s (ASNC) Annual Scientific Session, ASNC2018, will kick o
A myocardial perfusion exam performed on the Siemens Biograph Vision PET-CT system.

A myocardial perfusion exam performed on the Siemens Biograph Vision PET-CT system.

Feature | Nuclear Imaging | June 15, 2018 | Dave Fornell, Editor
Nuclear imaging technology for both sing...
CZT SPECT camera detectors offered by GE.

A display of CZT SPECT gamma camera detectors at RSNA 2016. These detectors are more sensitive than those used in older cameras, allowing for faster scans or lower radiation dose. 

Feature | Nuclear Imaging | September 19, 2017 | Dave Fornell
Cardiac nuclear myocardial perfusion imaging (MPI) has been a mature area of imaging for years, but has recently star
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Videos | Nuclear Imaging | August 24, 2017
Randy Thompson, M.D., attending cardiologist, St.
Overlay Init